**8. References**

Albrecht, J. (2010). "Hepatic encephalopathy in our genes?" *Ann Intern Med* 153(5): 335-6.


Bustamante, J., A. Rimola, et al. (1999). "Prognostic significance of hepatic encephalopathy in

Davies, N., Wright G, Ytrebo LM, Stadlbauer V, Fuskevag O-M, Zwingmann C, Davies DC,

Eurostat (2010). Accessed at <http://ec.europa.eu/health/ph\_information/dissemination

glutaminase and glutamine metabolism." *Nature* 458(7239): 762–765. Hawkins, R. A., J. Jessy, et al. (1994). "Neomycin reduces the intestinal production of

ammonia from glutamine." *Adv Exp Med Biol* 368: 125-34.

vascular homeostasis." *Nat Med* 13(2): 198-203.

human tumour cells." *Biochem. J.* 386: 535–542.

hepatic encephalopathy." *Metab Brain Dis* 20(4): 319-25.

Gao P, T. I., Chang T, Lee Y, Kita K, Ochi T, Zeller K, De Marzo AM, Van Eyk JE, Mendell JT

Heini Hans G., G. R., Brecht Andreas and Mecke Dieter (1987). "Purification and characterization of rat liver glutaminase." *Eur. J. Biochem* 162: 541 -546. Hui, A. Y., H. L. Chan, et al. (2002). "Survival and prognostic indicators in patients with

Jalan, R., G. Wright, et al. (2007). "L-Ornithine phenylacetate (OP): A novel treatment

Leiper, J., M. Nandi, et al. (2007). "Disruption of methylarginine metabolism impairs

Li, Q. and I. M. Verma (2002). "NF-kappaB regulation in the immune system." *Nat Rev* 

Montoliu, C., B. Piedrafita, et al. (2009). "IL-6 and IL-18 in blood may discriminate cirrhotic

Montoliu, C., R. Rodrigo, et al. (2010). "Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications." *Metab Brain Dis* 25(1): 39-48. Mookerjee, R. P., M. Malaki, et al. (2007). "Increasing dimethylarginine levels are

Olde Damink, S. W., R. Jalan, et al. (2002). "Interorgan ammonia and amino acid metabolism

Perez-Gomez C, C. S. J., Alonso FJ, Segura J, Manzanares E, Ruiz-Sanchez P, Gonzalez M,

Rama Rao, K. V., A. R. Jayakumar, et al. (2010). "Marked potentiation of cell swelling

Romero-Gomez, M. (2005). "Role of phosphate-activated glutaminase in the pathogenesis of

Habtesion A, Hodges SJ, Jalan R (2009). "L-ornithine and phenylacetate synergistically produces sustained reduction in amnonia and brain water in

and Dang CV (2009). "c-Myc suppression of miR-23 enhances mitochondrial

hepatitis B virus-related cirrhosis after onset of hepatic decompensation." J Clin

for hyperammonemia and hepatic encephalopathy." *Med Hypotheses* 69(5):

patients with and without minimal hepatic encephalopathy." *J Clin Gastroenterol*

associated with adverse clinical outcome in severe alcoholic hepatitis." *Hepatology*

in metabolically stable patients with cirrhosis and a TIPSS." *Hepatology* 36(5): 1163-

Marquez J, Mates JA (2005). "Co-expression of glutaminase K and L isoenzymes in

by cytokines in ammonia-sensitized cultured astrocytes." *J Neuroinflammation*

patients with cirrhosis." *J Hepatol* 30(5): 890-5.

cirrhotic rats." *Hepatology* Jul;50(1):155-164..

/echi/echi\_en.htm> on 26 July 2010.

*Gastroenterol* 34(5): 569-72.

*Immunol 2*(10): 725-34.

1064-9.

43(3): 272-9.

45(1): 62-71.

71.

7: 66.


Ytrebo, L. M., S. Sen, et al. (2006). "Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure." *Am J Physiol Gastrointest Liver Physiol* 291(3): G373-81.
